HF
ENVB icon

HRT Financial’s Enveric Biosciences ENVB Stock Holding History

HRT Financial’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Buy
+15,458
New +$37.1K ﹤0.01% 3918
2025
Q2 		– Sell
-3,385
Closed -$56K – 2865
2025
Q1 		$56K Buy
+3,385
New +$117K ﹤0.01% 2229
2024
Q3 		– Sell
-61
Closed -$6K – 2613
2024
Q2 		$6K Sell
61
-289
-83% -$43.6K ﹤0.01% 2029
2024
Q1 		$63K Buy
+350
New +$67.4K ﹤0.01% 1912
2022
Q3 		– Sell
-2
Closed -$2K – 2991
2022
Q2 		$2K Buy
+2
New +$4.25K ﹤0.01% 2801

Other funds holding ENVB

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HRT Financial's ENVB Position: Q2 2026 in Review

HRT Financial opened a new position in Enveric Biosciences (ENVB) in Q2 2026: 15,458 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #3918 among its holdings. This is a return to the name: HRT Financial previously reported a position in ENVB as recently as Q1 2025.

HRT Financial first reported a position in ENVB in Q2 2022 and has held it in 5 quarters since. The position peaked at $63K in Q1 2024. 24 funds tracked by Wall St. Rank hold ENVB as of Q2 2026.

  • HRT Financial held 15,458 shares of Enveric Biosciences worth $21K as of Q2 2026.
  • Enveric Biosciences was a new HRT Financial position in Q2 2026.
  • Enveric Biosciences made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3918 holding.
  • HRT Financial first reported a position in Enveric Biosciences in Q2 2022 and has held it in 5 quarters since.
  • HRT Financial's Enveric Biosciences position peaked at $63K in Q1 2024.
  • 24 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.